Cargando…
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
The first formal conference of the EUropean Federation for Exploratory MEdicines Development (EUFEMED) held in London was the result of a collaborative effort of its founding associations: the Association for Applied Human Pharmacology (AGAH; Germany), the Association for Human Pharmacology in the P...
Autores principales: | Van Bortel, Luc, Sourgens, Hildegard, Breithaupt-Grögler, Kerstin, Caplain, Henri, Donazzolo, Yves, Klingmann, Ingrid, Hammond, Michael, Hardman, Timothy C., Stringer, Steffan, de Hoon, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776107/ https://www.ncbi.nlm.nih.gov/pubmed/29387006 http://dx.doi.org/10.3389/fphar.2017.00901 |
Ejemplares similares
-
The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum
por: Breithaupt-Grögler, Kerstin, et al.
Publicado: (2019) -
European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development—Be Prepared
por: Hardman, Tim, et al.
Publicado: (2019) -
Use of integrated clinical trial protocols – A survey in early medicines development
por: Erb-Zohar, Katharina, et al.
Publicado: (2018) -
Unintended drug exposure during pregnancy in clinical trials – a survey in early drug development
por: Erb-Zohar, Katharina, et al.
Publicado: (2021) -
How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum
por: Rengelshausen, Jens, et al.
Publicado: (2021)